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Abstract
Background: 16S rRNA methylase-producing Gram-negative bacteria are highly resistant to all clinically important
aminoglycosides. We analyzed clinical strains of 16S rRNA methylase-producing Acinetobactor baumannii and
Pseudomonas aeruginosa obtained from clinical isolates in medical settings in Vietnam.
Methods: From 2008 to 2011, 101 clinical strains of A. baumannii and 15 of P. aeruginosa were isolated from
patients in intensive care units (ICUs) in two medical settings in Vietnam. Antimicrobial susceptibilities were
determined using the microdilution method and epidemiological analysis was performed by pulsed-field gel
electrophoresis and MLST. Genes encoding the 16S rRNA methylases, OXAs and CTX-Ms were analyzed by PCR and
sequence analysis.
Results: 16S rRNA methylase-producing Gram-negative pathogens were detected in two hospitals in Vietnam. Of
the 101 clinical isolates of A. baumannii and the 15 of P. aeruginosa isolated from two ICUs in these hospitals,
72 (71.3%) were highly resistant to amikacin, arbekacin and gentamicin, with MICs greater than 1,024 mg/L. The 16S
rRNA methylases ArmA and RmtB were produced by 61 and 9 isolates of A. baumannii, respectively, and RmtB was
produced by 2 isolates of P. aeruginosa. Moreover, 52 of the A. baumannii isolates producing 16S rRNA methylases
harbored both blaOXA-23-like and blaOXA-51-like genes. Most A. baumannii isolates producing 16S rRNA methylase
obtained in hospital A in Hanoi were ST91 and ST231, whereas most from hospital B in Ho Chi Minh City were ST136,
ST195, and ST254.
The two P. aeruginosa isolates harboring rmtB showed different patterns on PFGE, one each corresponding to ST217
and ST313.
Conclusions: Gram-negative bacteria producing the 16S rRNA methylases ArmA and RmtB are emerging in medical
settings in Vietnam. A. baumannii isolates in northern and southern regions of Vietnam may be of different lineages.
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Background
Aminoglycosides widely used to treat infectious diseases
caused by Gram-negative bacteria have a high affinity for
the 16S rRNA of the bacterial 30S ribosome and block
protein synthesis [1]. Enzymatic modification [1] and the
methylation of 16S rRNA makes these bacteria highly
resistant to all clinically important aminoglycosides [2]. In
2003, clinical isolates of highly aminoglycoside-resistant
Gram-negative bacteria producing16S rRNA methylase
were identified in France [3] and Japan [4]. Since then, 16S
rRNA methylase-producing Gram-negative bacteria have
been isolated in other parts of the world, including Asian
countries such as Afghanistan, Bangladesh, China, Hong
Kong, India, Japan, Korea, Oman and Pakistan [5]. To
date, however, there have been no reports of these isolates
from South-East Asian countries, including Vietnam.
Since 2003, eight plasmid-associated 16S rRNA methyl-
ase genes, armA, rmtA, rmtB, rmtC, rmtD, rmtE, rmtF
and npmA, have been identified in clinical and veterinary
isolates from various geographic areas, including East
Asia, Europe and the Americas, since 2003 [5,6].
Methods
Bacterial strains
From 2008 to 2011, 50 clinical strains of A. baumannii
and 15 of P. aeruginosa were isolated from patients in
an ICU in hospital A in Hanoi, Vietnam; and 51 strains
of A. baumannii were isolated from patients in an ICU
in hospital B in Ho Chi Minh City, Vietnam. Of the 101
A. baumannii strains isolated, 98 were from patients’ re-
spiratory tracts and 3 from blood. Of the 15 P. aeruginosa
strains, 14 were from respiratory tracts and 1 from pus.
Most patients were on ventilators, and the samples were
mostly aspirates from ventilation tubes. All clinical isolates
used in this study were obtained during standard patient
care.
Antimicrobial susceptibility and pulsed-field gel
electrophoresis (PFGE)
MICs of all bacteria to amikacin (Sigma-Aldrich, St. Louis,
MO), arbekacin (Meiji Seika Pharma Co., Tokyo, Japan),
aztreonam (Eizai, Tokyo, Japan), ceftadizime (Sigma-
Aldrich), ciprofloxacin (Daiichi Pharmaceutical Co, Tokyo,
Japan), colistin (Sigma-Aldrich), gentamicin (Nacalai
Tesque, Kyoto, Japan), imipenem (Banyu Pharmaceutical
Co, Tokyo, Japan), meropenem (Sumitomo Pharmaceutical
Co., Osaka, Japan), piperacillin (Sigma-Aldrich) and
pipiracillin/tazobactam (Toyama Chemical Co., Tokyo,
Japan) were determined using the microdilution
method, according to the guidelines of the Clinical and
Laboratory Standards Institute (M07-A9). A. baumannii
DNA was digested with the restriction enzyme ApaI
and P. aeruginosa DNA was digested with SpeI, followed
by pulsed-field gel electrophoresis (PFGE). PFGE analysis
was performed as described previously [7]. Fingerprinting
patterns were analyzed by the unweighted-pair-group
method using Molecular Analyst Fingerprinting Plus soft-
ware (Bio-Rad Laboratories, Hercules, CA, USA) to create
an average linkage-based dendrogram.
Multilocus sequence typing (MLST)
MLST of 16S rRNA methylase-producing pathogens
was performed according to the protocols described on
the A. baumannii (http://pubmlst.org/abaumannii/) and
P. aeruginosa (http://pubmlst.org/paeruginosa/) MLST
Database websites. Seven chromosomal genes were PCR
amplified and sequenced, with their nucleotide sequences
compared with the sequences submitted to the MLST
database to determine allele numbers and STs.
Detection of aminoglycoside-resistant genes
PCR with 16S rRNA methylase gene specific primers
[2,8,9] was performed to detect the armA, rmtA, rmtB,
rmtC, rmtD, rmt E and npmA genes. All PCR amplicons
were sequenced using an ABI PRISM 3130 sequencer
(Applied Biosystems, Foster City, CA, USA).
Whole genomes of methylase-negative A. baumannii
and P. aeruginosa, which had MICs 128 mg/L to amikacin,
32 mg/L to arbekacin and 128 mg/L to gentamicin, were
extracted by DNeasy Blood & Tissue kit (QIAGEN, Tokyo,
Japan) and sequenced by MiSeq (Illumina, San Diego, CA).
The sequence data were used to confirm aminoglycoside-
resistant genes.
Detection of OXAs and CTX-Ms encoding genes
The presence of blaOXA-23-like, blaOXA-24-like,
blaOXA-51-like, blaOXA-58-like and blaCTX-Ms in
16S rRNA methylase-producing isolates were investi-
gated by PCR [10,11].
Determination of the genetic environment surrounding
rmtB
A draft genome sequence of an isolate of A. baumannii,
NCGM36, harboring rmtB was determined using the GS
Junior System (Roche Diagnostics K.K, Tokyo).
Ethical approval
This study was approved in 2007 by Ministry of Health,
Bach Mai Hospital (Memorandum of agreement for the
collaborative research project on epidemiology of nosoco-
mial infections at the Bach Mai Hospital) and in 2011 by
Cho Ray Hospital (approval number: 1644/QD-BVCR),
and by the Biosafety Committee, National Center for
Global Health and Medicine (approval number: 23-M-49).
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Results
Antimicrobial susceptibility and aminoglycoside-resistant
genes
The MICs at which 50% and 90% of the 101 A.
baumannii and 15 P. aeruginosa isolates were inhibited
(MIC50 and MIC90, respectively) were determined
(Table 1). Seventy of the 101 A. baumannii isolates
(71.3%) had MICs >1,024 mg/L to all aminoglycosides
tested, including amikacin, arbekacin and gentamicin.
All 70 isolates had 16S rRNA methylases, with 61 having
armA and the remaining 9 having rmtB (Figure 1). The
remaining 31 isolates had MICs ≤128 mg/L to amikacin,
≤32 mg/L to arbekacin and ≤128 mg/L to gentamicin
and no methylase genes. Whole genome sequencing of 2
methylase-negative isolates showing relative resistance
to aminoglycosides revealed that one had aac(6’)-IIb and
aadB and that the other had aac(6’)-IIb and aadA2.
Of the 15 P. aeruginosa isolates, 2 had MICs
>1,024 mg/L to amikacin, arbekacin and gentamicin, and
harbored the 16S rRNA methylase rmtB (Figure 2). The
13 methylase-negative isolates had MICs <2 - 256 mg/L
to amikacin (MIC50 64 mg/L and MIC90 128 mg/L), 1–
32 mg/L to arbekacin (MIC50 2 mg/L and MIC90 4 mg/L),
and 1–32 mg/L to <0.5 - 512 mg/L to gentamicin (MIC50
256 mg/L and MIC90 512 mg/L). The remaining 13 did
not have any methylase genes (Figure 2).
OXAs and CTX-Ms encoding genes in 16S rRNA
methylase-producing isolates
Of the 61 A. baumannii isolates harboring armA, 1 had
blaOXA-23-like, blaOXA-51-like and blaCTX-Ms genes,
51 had blaOXA-23-like and blaOXA-51-like genes, and 8
had blaOXA-51-like genes. All 9 A. baumannii isolates
harboring rmtB had blaOXA-23-like and blaOXA-51-like
genes. In contrast, the 2 P. aeruginosa isolates harbor-
ing16S rRNA methylase genes had neither the blaOXAs
nor the blaCTX-Ms gene.
PFGE analysis and MLST
PFGE analysis of the 101 A. baumannii isolates revealed
8 clusters (Figure 1). Isolates from Clusters I, III, IV, V,
VI, VII, and VIII were obtained from either one or the
other hospital, whereas isolates from Clusters II and III
were obtained from both. These results indicate that A.
baumannii isolates had expanded in a clonal manner in
both hospitals and that some isolates may spread among
hospitals in Vietnam.
The16S rRNA methylase-encoding the rmtB gene was
detected in Cluster I A. baumannii isolates, whereas
armA was present in isolates from Clusters I, III, IV, V,
VI, VII, and VIII. Isolates harboring rmtB were obtained
from one hospital and isolates harboring armA were
from both hospitals.
The A. baumannii isolates producing 16S rRNA methyl-
ase belonged to ST254, ST231, ST195, ST136, ST91 and 8
new STs, ST490, ST491, ST492, ST493, ST494, ST495,
ST496 and ST497 (Figure 1). Most of the A. baumannii
isolates producing 16S rRNA methylase from hospital A in
Hanoi were ST91 and ST231, whereas most from hospital
B in Ho Chi Minh City were ST136, ST195 and ST254.
The two isolates harboring rmtB showed different
patterns on PFGE, belonging to ST217 and ST313.
Genetic environment surrounding rmtB
The rmtB gene was associated with an ISCR3 mobile
element upstream and a Tn3 transposon structure



























Amikacin ≥64 85 <2- > 1024 >1024 >1024 ≥64 60 <2- > 1024 64 >1024
Arbekacin - - <2- > 1024 >1024 >1024 - - 2- > 1024 2 >1024
Aztreonam - - <2- > 256 128 >256 ≥32 46 4- > 256 16 >256
Ceftazidime ≥32 55 <4- > 512 >512 >512 ≥32 46 <4- > 512 16 >512
Ciprofloxacin ≥4 98 <1- > 128 128 >128 ≥4 66 <1-64 8 32
Colistin ≥4 6 <0.25-4 2 2 ≥8 0 <0.25-0.5 <0.25 0.5
Gentamicin ≥16 91 <2- > 1024 >1024 >1024 ≥16 66 <2- > 1024 256 >1024
Imipenem ≥16 48 <4-128 16 32 ≥8 53 <4-64 16 32
Meropenem ≥16 51 <4- > 256 32 64 ≥8 53 <4-32 16 32
Piperacillin ≥128 100 <4- > 512 >512 >512 ≥128 46 <4- > 512 32 256
Piperacillin/
Tazobactam
≥128/4 52 <4- > 512 256 512 ≥128/4 13 <4-512 32 128
aBreakpoints for antimicrobial resistance were determined according to the guidelines of the Clinical and Laboratory Standards Institute (M07-A9).
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blaTEM-1-tnpR-tnpA downstream (data not shown).
The genetic environment of rmtB had more than 99.9%
nucleotide sequence identity, from nucleotide 1 to
8,337, to plasmid pXD2 (Gen bank accession no.
JN315966) in E. coli, which causes bovine milk mastitis
in China [12]. NCGM36, which harbored rmtB, had
the blaOXA-23 and blaOXA-68 genes, but had neither
the aac(6’)-Ib-cr nor the blaCTX-Ms gene.
Discussion
The high prevalence of 16S rRNA methylase producing
Gram-negative bacteria in hospitals in Vietnam may have
resulted from the high rate of use of aminoglycosides. It
has been estimated that 67.4% of hospitalized patients
in Vietnam received antibiotics, including 18.9% who
received aminoglycosides, with many 30.8% of these
prescriptions considered inappropriate [13]. This rate of
antibiotic use was much higher than in European coun-
tries (17.8%-32.0%) [14,15]. Moreover, the rate of in-
appropriate indications for antibiotic prescriptions in
hospitals in Vietnam was much higher than rates
reported in Malaysia (4.0%) [16], Turkey (14.0%) [17],
and Hong Kong (20.0%) [18].
A. baumannii isolates from the northern and southern
regions of Vietnam may be of different lineages. To date, 2
strains of A. baumannii showing ST91 and 3 showing
ST136 have been isolated in China; 6 strains showing
ST195 have been isolated, 1 in Norway, 2 in Thailand, 2 in
Figure 1 PFGE pattern and MLST analysis of 101 Acinetobacter
baumannii isolates. Eight clusters (I-VIII) with more than 70%
similarity were identified. Isolates harboring armA (●) and rmtB (○)
are shown in the column on the right.
Figure 2 PFGE pattern and MLST analysis analysis of 15
Pseudomonas aeruginosa isolates. Eight clusters with more than
70% similarity were detected. Two clusters (I and II) with more than
70% similarity were identified. Isolates harboring rmtB (○) are shown
in the column on the right.
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Malaysia and 1 in China;, 5 strains showing ST231 have
been isolated in Brazil and 1 strain showing ST254 has
been isolated in China (http://pubmlst.org/abaumannii/).
ST136 and ST195 belong to clonal complex 92, the most
widely disseminated complex worldwide [19]. Two strains
of P. aeruginosa producing RmtB, showing ST217 and
ST313, may have originally derived from Europe or
Australia, because, to date, P. aeruginosa ST217 isolates
were obtained only in the United Kingdom and ST313
isolates only in Australia, France and Hungary [20]
(http://pubmlst.org/paeruginosa/).
To our knowledge, this is the first report showing that
A. baumannii strains harboring a 16S rRNA methylase
(ArmA or RmtB) and with blaOXA-23-like and blaOXA-
51-like genes are emerging in medical settings in Vietnam.
ArmA and OXA-23-like producing Gram-negative patho-
gens have been reported in Bulgaria [21], France [22],
India [23], Korea [24], Norway [25] and the United States
of America [26], and ArmA and OXA-51-like producing
strains have been reported in Japan [27]. Moreover, armA
and rmtB have been linked to blaCTX-Ms [28,29], but
almost all ArmA producing isolates in Vietnam did not
harbor blaCTX-Ms.
We found that some A. baumannii clinical isolates
harbored rmtB. The genetic environment of the rmtB
regions was very similar to the nucleotide sequence,
from nt 1 to nt 8,337, of the plasmid pXD2. However,
the plasmid of NCGM36 likely differs from pXD2 (Gen
bank accession no. JN315966), in that the former
NCGM36 did not have aac(6’)-Ib or blaCTX-Ms.
Since 16S rRNA methylase genes in A. baumannii and
P. aeruginosa are located in transferable plasmids [5],
the absence of methylase genes was found in the same
PFGE clusters. The details of these plasmids will be
reported elsewhere.
We plan to survey Gram-negative pathogens producing
16S rRNA methylases in 2013 in Vietnam, since more
than 9 Gram-negative bacteria producing 16S rRNA
methylases have been reported, including A. baumannii,
Citrobacter freundii, Enterobacter spp (including E. clo-
acae), Escherichia coli, Klebsiella pneumonia, Morganella
morganii, Proteus mirabilis, Providencia spp (including P.
stuartii), and P. aeruginosa [5].
Conclusions
This is the first report describing the presence of meth-
ylase producing Gram-negative bacteria in medical set-
tings in Southeast Asia, specifically in Vietnam. A.
baumannii isolates from northern and southern regions
of Vietnam may be of different lineages.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TT: Performed PCR and sequencing, analyzed data and drafted the
manuscript. TMA: Performed MLST analyses. YK, NO, NT and TAT: Performed
epidemiological analysis at BMH. NVH, NGB and NQA: Designed protocols
and supervised this study at BMH. DMP, TTTN and PHT: Performed clinical
bacterial analyses. PTX: Performed epidemiological analysis at CRH. LTAT and
NTS: Designed protocols and supervised this study at CRH. TK: Designed
protocols and supervised this study. All authors read and approved the final
version manuscript.
Acknowledgments
This study was supported by a grant (H24-Shinko-ippan-010) from the
Ministry of Health, Labor and Welfare of Japan, and JSPS KAKENHI Grant
Number 24790432. We thank Mrs. Kayo Shimada for PFGE analyses.
Author details
1Department of Infectious Diseases, National Center for Global Health and
Medicine, Shinjuku, Tokyo 162-8655, Japan. 2Disease Control and Prevention
Center, National Center for Global Health and Medicine, Shinjuku, Japan.
3Disease Control and Prevention Center, Division of Infectious Diseases,
National Center for Global Health and Medicine, Shinjuku, Japan. 4Bach Mai
Hospital, Hanoi, Vietnam. 5Cho Ray Hospital, Ho Chi Minh, Vietnam.
Received: 19 December 2012 Accepted: 7 May 2013
Published: 30 May 2013
References
1. Jana S, Deb JK: Molecular understanding of aminoglycoside action and
resistance. Appl Microbiol Biotechnol 2006, 70(2):140–150.
2. Doi Y, Arakawa Y: 16S ribosomal RNA methylation: emerging resistance
mechanism against aminoglycosides. Clin Infect Dis 2007, 45(1):88–94.
3. Galimand M, Courvalin P, Lambert T: Plasmid-mediated high-level
resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA
methylation. Antimicrob Agents Chemother 2003, 47(8):2565–2571.
4. Yamane K, Wachino J, Suzuki S, Shibata N, Kato H, Shibayama K, Kimura K,
Kai K, Ishikawa S, Ozawa Y, Konda T, Arakawa Y: 16S rRNA methylase-
producing, gram-negative pathogens, Japan. Emerg Infect Dis 2007,
13(4):642–646.
5. Wachino J, Arakawa Y: Exogenously acquired 16S rRNA
methyltransferases found in aminoglycoside-resistant pathogenic Gram-
negative bacteria: An update. Drug Resist Updat 2012, 15(3):133–148.
6. Yokoyama K, Doi Y, Yamane K, Kurokawa H, Shibata N, Shibayama K, Yagi T,
Kato H, Arakawa Y: Acquisition of 16S rRNA methylase gene in
Pseudomonas aeruginosa. Lancet 2003, 362(9399):1888–1893.
7. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M,
Fujino T, Kikuchi H, Sasaki S, Watari H, Kojima T, Miki H, Kanemitsu K,
Kunishima H, Kikuchi Y, Kaku M, Yoshikura H, Kuratsuji T, Kirikae T:
Outbreaks of multidrug-resistant Pseudomonas aeruginosa in
community hospitals in Japan. J Clin Microbiol 2007, 45(3):979–989.
8. Davis MA, Baker KN, Orfe LH, Shah DH, Besser TE, Call DR: Discovery of a
gene conferring multiple-aminoglycoside resistance in Escherichia coli.
Antimicrob Agents Chemother 2010, 54(6):2666–2669.
9. Zhou Y, Yu H, Guo Q, Xu X, Ye X, Wu S, Guo Y, Wang M: Distribution of
16S rRNA methylases among different species of Gram-negative bacilli
with high-level resistance to aminoglycosides. Eur J Clin Microbiol Infect
Dis 2010, 29(11):1349–1353.
10. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes
SG, Livermore DM: Multiplex PCR for genes encoding prevalent OXA
carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006,
27(4):351–353.
11. Monstein HJ, Ostholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K,
Nilsson LE: Multiplex PCR amplification assay for the detection of blaSHV,
blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS 2007,
115(12):1400–1408.
12. Li DX, Zhang SM, Hu GZ, Wang Y, Liu HB, Wu CM, Shang YH, Chen YX, Du
XD: Tn3-associated rmtB together with qnrS1, aac(6′)-Ib-cr and bla CTX-
M-15 are co-located on an F49:A-:B- plasmid in an Escherichia coli ST10
strain in China. J Antimicrob Chemother 2012, 67(1):236–238.
13. Thu TA, Rahman M, Coffin S, Harun-Or-Rashid M, Sakamoto J, Hung NV:
Antibiotic use in Vietnamese hospitals: A multicenter point-prevalence
study. Am J Infect Control 2012, 40(9):840–844.
Tada et al. BMC Infectious Diseases 2013, 13:251 Page 5 of 6
http://www.biomedcentral.com/1471-2334/13/251
14. Hulscher ME, Grol RP, van der Meer JW: Antibiotic prescribing in hospitals:
a social and behavioural scientific approach. Lancet Infect Dis 2010,
10(3):167–175.
15. Kritsotakis EI, Dimitriadis I, Roumbelaki M, Vounou E, Kontou M,
Papakyriakou P, Koliou-Mazeri M, Varthalitis I, Vrouchos G, Troulakis G, Gikas
A: Case-mix adjustment approach to benchmarking prevalence rates of
nosocomial infection in hospitals in Cyprus and Greece. Infect Control
Hosp Epidemiol 2008, 29(8):685–692.
16. Hughes AJ, Ariffin N, Huat TL, Abdul Molok H, Hashim S, Sarijo J, Abd Latif
NH, Abu Hanifah Y, Kamarulzaman A: Prevalence of nosocomial infection
and antibiotic use at a university medical center in Malaysia.
Infect Control Hosp Epidemiol 2005, 26(1):100–104.
17. Ceyhan M, Yildirim I, Ecevit C, Aydogan A, Ornek A, Salman N, Somer A,
Hatipoglu N, Camcioglu Y, Alhan E, Celik U, Hacimustafaoglu M, Celebi S,
Inan D, Kurt N, Oner AF, Gulumser O, Gunes A, Coskun Y: Inappropriate
antimicrobial use in Turkish pediatric hospitals: a multicenter point
prevalence survey. Int J Infect Dis 2010, 14(1):e55–e61.
18. Lee MK, Chiu CS, Chow VC, Lam RK, Lai RW: Prevalence of hospital
infection and antibiotic use at a university medical center in Hong Kong.
J Hosp Infect 2007, 65(4):341–347.
19. Hamouda A, Evans BA, Towner KJ, Amyes SG: Characterization of
epidemiologically unrelated Acinetobacter baumannii isolates from four
continents by use of multilocus sequence typing, pulsed-field gel
electrophoresis, and sequence-based typing of bla(OXA-51-like) genes.
J Clin Microbiol 2010, 48(7):2476–2483.
20. Libisch B, Watine J, Balogh B, Gacs M, Muzslay M, Szabo G, Fuzi M:
Molecular typing indicates an important role for two international clonal
complexes in dissemination of VIM-producing Pseudomonas aeruginosa
clinical isolates in Hungary. Res Microbiol 2008, 159(3):162–168.
21. Strateva T, Markova B, Marteva-Proevska Y, Ivanova D, Mitov I: Widespread
dissemination of multidrug-resistant Acinetobacter baumannii producing
OXA-23 carbapenemase and ArmA 16S ribosomal RNA methylase in a
Bulgarian university hospital. Braz J Infect Dis 2012, 16(3):307–310.
22. Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P: PER-7, an
extended-spectrum beta-lactamase with increased activity toward
broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob
Agents Chemother 2011, 55(5):2424–2427.
23. Karthikeyan K, Thirunarayan MA, Krishnan P: Coexistence of blaOXA-23
with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii
from India. J Antimicrob Chemother 2010, 65(10):2253–2254.
24. Kim JW, Heo ST, Jin JS, Choi CH, Lee YC, Jeong YG, Kim SJ, Lee JC:
Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla
(PER-1) and armA in a Korean hospital. Clin Microbiol Infect 2008,
14(7):716–718.
25. Karah N, Haldorsen B, Hermansen NO, Tveten Y, Ragnhildstveit E, Skutlaberg
DH, Tofteland S, Sundsfjord A, Samuelsen O: Emergence of OXA-
carbapenemase- and 16S rRNA methylase-producing international
clones of Acinetobacter baumannii in Norway. J Med Microbiol 2011,
60(Pt 4):515–521.
26. Doi Y, Adams JM, Yamane K, Paterson DL: Identification of 16S rRNA
methylase-producing Acinetobacter baumannii clinical strains in North
America. Antimicrob Agents Chemother 2007, 51(11):4209–4210.
27. Yamada Y, Suwabe A: Diverse carbapenem-resistant mechanisms in 16S
rRNA methylase-producing Acinetobacter baumannii. J Med Microbiol
2013, 62(4):618–622.
28. Galimand M, Sabtcheva S, Courvalin P, Lambert T: Worldwide disseminated
armA aminoglycoside resistance methylase gene is borne by composite
transposon Tn1548. Antimicrob Agents Chemother 2005, 49(7):2949–2953.
29. Ma L, Lin CJ, Chen JH, Fung CP, Chang FY, Lai YK, Lin JC, Siu LK: Taiwan
Surveillance of Antimicrobial Resistance Project: Widespread
dissemination of aminoglycoside resistance genes armA and rmtB in
Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type
extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2009,
53(1):104–111.
doi:10.1186/1471-2334-13-251
Cite this article as: Tada et al.: Emergence of 16S rRNA methylase-
producing Acinetobacter baumannii and Pseudomonas aeruginosa
isolates in hospitals in Vietnam. BMC Infectious Diseases 2013 13:251.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tada et al. BMC Infectious Diseases 2013, 13:251 Page 6 of 6
http://www.biomedcentral.com/1471-2334/13/251
